HIV and AIDS News

December 24, 2024

Top Headlines

After Lockdown, Immune System Reacts More Strongly to Viruses and Bacteria

Dec. 18, 2024 — New research shows that the lockdowns during the COVID-19 pandemic had a significant impact on people's immune response to microorganisms. During the lockdown, inflammation level in the body was low, but afterwards, the immune system reacted more ...

Study Assesses Virulence of Cryptococcus Strains, Laying Groundwork for Improved Treatment

Dec. 16, 2024 — A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize plaques and ...

Updated Hep B Vaccine More Effective for People With HIV

Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

Latest Headlines

updated 8:18pm EST

Clinical Trial Reveals Twice-Yearly Injection to Be 96% Effective in HIV Prevention

Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring ...

HIV Latency Reversing Properties in African Plant

Nov. 19, 2024 — The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree ...

When Hepatitis E Viruses Attack Nerve Cells

Nov. 18, 2024 — Hepatitis E viruses (HEV) typically cause liver infections. They can, however, also infect other organs and cause neurological disorders. Little is yet known about how this process works. A research ...

Probability Training: Preventing Errors of Reasoning in Medicine and Law

Nov. 6, 2024 — A new study shows how students can better understand and interpret conditional ...

Study Demonstrates Efficacy of Iron Supplements for Children Living With HIV

Oct. 31, 2024 — A research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an ...

Kidney Transplantation Among Those With HIV Infections Shown Safe and Effective, Study Suggests

Oct. 17, 2024 — It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it ...

Promising TB Therapy Appears Safe for Patients With HIV

Oct. 1, 2024 — A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), according to new ...

A Viral Close-Up of HTLV-1

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus, understanding its ...

A Two-Dose Schedule Could Make HIV Vaccines More Effective

Sep. 20, 2024 — Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week ...

Targeted Immune Intervention and Stopping ART in Model of SIV Infection Leads to Control of Viral Replication and Reservoirs

Sep. 12, 2024 — Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the ...

Sub-Saharan Africa Leads Global HIV Decline

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ambitious UNAIDS 2030 ...

An Antidiabetic Helps the Immune System Recognize Reservoirs of HIV

Sep. 10, 2024 — Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral ...

Potential Link Between DNA Markers and Aging Process

Aug. 19, 2024 — Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological ...

New Drug Shows Promise in Clearing HIV from Brain

July 25, 2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus ...

Proof-of-Concept Study to Find Functional Cure for HIV

July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need for lifelong ...

Long-Acting Injectable Cabotegravir for HIV Prevention Is Safe in Pregnancy, Study Finds

July 23, 2024 — Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender ...

B Cell Biohack: Immune Cells to Churn out Custom Antibodies

July 22, 2024 — Scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, ...

Exposing Dengue's Invasion Strategies

July 22, 2024 — Mosquito-borne viral infections once confined to tropical regions are spreading. Dengue virus infects up to 400 million people worldwide each year according to World Health Organization estimates, ...

Study Shows Promise for a Universal Influenza Vaccine

July 19, 2024 — New research reveals a promising approach to developing a universal influenza vaccine -- a so-called 'one and done' vaccine that confers lifetime immunity against an evolving virus. The ...

Improving HIV Treatment in Children and Adolescents -- The Right Way

July 18, 2024 — Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than ...

Autoantibodies Behind Lifelong Risk of Viral Infections

July 17, 2024 — A new study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like ...

Llama Nanobodies: A Breakthrough in Building HIV Immunity

July 17, 2024 — Biology researchers have developed a new antibody therapy that can neutralize a wide variety of HIV-1 strains. They found success in an unlikely source -- ...

Cirrhosis Affects Twice as Many Transgender Adults as Cisgender Adults, Study Finds

July 10, 2024 — A new study has found a startling disparity in the frequency of liver disease for transgender individuals and highlights the need for more specialized ...

Advancing Toward a Preventative HIV Vaccine

July 2, 2024 — A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast. Although a person initially becomes infected with one or a few HIV strains, the virus replicates and ...

Novel Vaccine Concept Generates Immune Responses That Could Produce Multiple Types of HIV Broadly Neutralizing Antibodies

May 30, 2024 — Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly ...

Researchers Take Step Toward Development of Universal COVID-19 Antibodies

May 30, 2024 — A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of ...

A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans

May 17, 2024 — An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical ...

An Active Agent Against Hepatitis E

May 15, 2024 — At present, there is no specific active substance against hepatitis E. As the disease kills 70,000 people every year, researchers are actively searching for one. A team may have found what ...

GPS-Like System Shows Promise as HIV Vaccine Strategy to Elicit Critical Antibodies

May 9, 2024 — A team has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against ...

US Geographic Region Results in Vastly Different Anal Cancer Risk for People With HIV

May 7, 2024 — For people with HIV, the risk of anal cancer varies according to their geographic ...